Till startsida
University of Gothenburg
Sitemap
To content Read more about how we use cookies on gu.se

Profile

Thomas Bourgeron is a Visiting Professor at the Gillberg Neuropsychiatry Centre. He is a member of the European Molecular Biology Organisation (EMBO), a member of the French academy of Science and of the Academia Europaea. He is the PI of the genetic work package of the EU-AIMS, the largest European project on autism research. After a Master in the field of plant biology, Thomas Bourgeron obtained his Ph.D. in human genetics to study mitochondrial diseases. He identified the first mutations of the Krebs cycle (FH) and of the nuclear genes of the respiratory chain (SDHA) in humans. He then obtained a position as Professor at the University Paris Diderot and established a laboratory at the Institut Pasteur to study the genetics of autism spectrum disorders (ASD). In 2003, he identified the first biological pathway associated with ASD that includes synaptic cell adhesion molecules (NLGN3, NLGN4, NRXN1) or scaffolding protein (SHANK2 and SHANK3). These proteins are crucial for appropriate synaptic function. His group also identified genetic mutations disrupting melatonin synthesis, which could contribute to the sleep problems observed in individuals with ASD. In parallel, he characterised the deficits in social communication of several mouse models of ASD lacking synaptic proteins such as SHANK2 or SHANK3. His present research is focused on the genetic architecture of ASD. His approach combines the state of the art genetics (such as whole genome sequencing) with original phenotyping approaches using brain imaging, biochemistry, induced pluripotent stem cells (iPSC) and in-depth clinical evaluations of the patients as well as the unaffected relatives. His multidisciplinary group of geneticists, neurobiologists, and clinicians, aims to provide knowledge-based discoveries for a better diagnostic, care, and integration of individuals with autism.

Publications

2016

Bourgeron, T. (2016). Current knowledge on the genetics of autism and propositions for future research. Comptes rendus biologies, 339, 300-307.

Bourgeron, T. (2016). The genetics and neurobiology of ESSENCE: The third Birgit Olsson lecture. Nordic Journal of Psychiatry, 70, 1-9.

Darville, H., Poulet, A., Rodet-Amsellem, F., Chatrousse, L., Pernelle, J., Boissart, C., ... Benchoua, A. (2016). Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome. EBioMedicine, 9, 293-305.

Ferhat, A.T., Torquet, N., Le Sourd, A.M., de Chaumont, F, Olivo-Marin, J.C., Faure, P.... Ey, E. (2016). Recording Mouse Ultrasonic Vocalizations to Evaluate Social Communication. Journal of Visualized Experiments, 112.

Huguet, G., & Bourgeron, T. (2016). The genetic causes of autism spectrum disorders. In: C. Sala & C. Verpelli (eds.), Neuronal and Synaptic Dysfunction in Autism Spectrum Disorder and Intellectual Disability. Elsevier.

Loth, E., Spooren, W., Ham, L.M., Isaac, M.B., Auriche-Benichou, C., Banaschewski, T., ... Murphy, D.G. (2016). Identification and validation of biomarkers for autism spectrum disorders. Nature Reviews, 15, 70-73.

Mercati, O., Huguet, G., Danckaert, A., André-Leroux, G., Maruani, A., Bellinzoni, M., ... Bourgeron, T. (2016). CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders. Molecular Psychiatry, (Epub ahead of print).

Mosca-Boidron, A.L., Gueneau, L., Huguet, G., Goldenberg, A., Henry, C., Gigot, N., ... Bourgeron, T. (2016). A de novo microdeletion of SEMA5A in a boy with autism spectrum disorder and intellectual disability. European Journal of Human Genetics, 24, 838-843.

Torrico, B., Chiocchetti, A.G., Bacchelli, E., Trabetti, E., Hervás, A., Franke, B., ... Toma, C. (2016). Lack of replication of previous autism spectrum disorder GWAS hits in European populations. Autism Research, (Epub ahead of print).

2015

Bourgeron T. (2015). From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nature Reviews, 16, 551-563.

Bourgeron, T., Xu, Z., Doumic, M., & Teresa Teixeira, M. (2015). The asymmetry of telomere replication contributes to replicative senescence heterogeneity. Scientific Reports, 5, 15326.

Ferhat, A.T., Le Sourd, A.M., de Chaumont, F., Olivo-Marin, J.C., & Bourgeron, T., & Ey, E. (2015). Social communication in mice--are there optimal cage conditions? PLoS One, 10, e0121802.

Gouder, L., Tinevez, J.Y., Goubran-Botros, H., Benchoua, A., Bourgeron, T., & Cloëz-Tayarani I. (2015). Three-dimensional Quantification of Dendritic Spines from Pyramidal Neurons Derived from Human Induced Pluripotent Stem Cells. Journal of Visualized Experiments, 104.

Lefebvre, A., Beggiato, A., Bourgeron, T., & Toro, R. (2015). Neuroanatomical Diversity of Corpus Callosum and Brain Volume in Autism: Meta-analysis, Analysis of the Autism Brain Imaging Data Exchange Project, and Simulation. Biological Psychiatry, 78, 126-134.

Maruani, A., Huguet, G., Beggiato, A., ElMaleh, M., Toro, R., Leblond, C.S., ... Delorme R. (2015). 11q24.2-25 micro-rearrangements in autism spectrum disorders: Relation to brain structures. American Journal of Medical Genetics. Part A, 167, 3019-3030.

Pinel, P., Lalanne, C., Bourgeron, T., Fauchereau, F., Poupon, C., Artiges, E., ... Dehaene, S. (2015). Genetic and Environmental Influences on the Visual Word Form and Fusiform Face Areas. Cerebral Cortex, 25, 2478-2493.

Toro, R., Poline, J.B., Huguet, G., Loth, E., Frouin, V., Banaschewski, T., ... Bourgeron, T. (2015). Genomic architecture of human neuroanatomical diversity. Molecular Psychiatry, 20, 1011-1016.

2014

Fernell, E., Wilson, P., Hadjikhani, N., Bourgeron, T., Neville, B., Taylor, D., . . . Gillberg, C. (2014). Screening, intervention and outcome in autism and other developmental disorders: the role of randomized controlled trials. Journal of Autism and Developmental Disorders, 44, 2074-2076.

Guilmatre, A., Huguet, G., Delorme, R., & Bourgeron, T. (2014). The emerging role of SHANK genes in neuropsychiatric disorders. Developmental Neurobiology, 74, 113-122.

Hadley, D., Wu, Z.L., Kao, C., Kini, A., Mohamed-Hadley, A., Thomas, K., … Hakonarson, H. (2014). The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism. Nature Communications, 5, 4074.

Huguet, G., Nava, C., Lemiere, N., Patin, E., Laval, G., Ey, E., . . . Bourgeron, T. (2014). Heterogeneous pattern of selective pressure for PRRT2 in human populations, but no association with autism spectrum disorders. PLoS One, 9, e88600.

Karayannis, T., Au, E., Patel, J. C., Kruglikov, I., Markx, S., Delorme, R., . . . Fishell, G. (2014). Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature, 511, 236-240.

Kleijer, K. T., Schmeisser, M. J., Krueger, D. D., Boeckers, T. M., Scheiffele, P., Bourgeron, T., . . . Burbach, J. P. (2014). Neurobiology of autism gene products: towards pathogenesis and drug targets. Psychopharmacology (Berl), 231, 1037-1062.

Kocovska, E., Andorsdottir, G., Weihe, P., Halling, J., Fernell, E., Stora, T., . . . Gillberg, C. (2014). Vitamin d in the general population of young adults with autism in the faroe islands. Journal of Autism and Developmental Disorders, 44, 2996-3005.

Leblond, C. S., Nava, C., Polge, A., Gauthier, J., Huguet, G., Lumbroso, S., . . . Bourgeron, T. (2014). Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments. PLoS Genetics, 10, e1004580.

Pagan, C., Delorme, R., Callebert, J., Goubran-Botros, H., Amsellem, F., Drouot, X., . . . Launay, J. M. (2014). The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders. Translational Psychiatry, 4, e479.

Pinto, D., Delaby, E., Merico, D., Barbosa, M., Merikangas, A., Klei, L., . . . Scherer, S. W. (2014). Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. American Journal of Human Genetics, 94, 677-694.

Waltes, R., Duketis, E., Knapp, M., Anney, R. J., Huguet, G., Schlitt, S., . . . Chiocchetti, A. G. (2014). Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders. Human Genetics, 133, 781-792.

2013

Boissart, C., Poulet, A., Georges, P., Darville, H., Julita, E., Delorme, R., ... Benchoua, A. (2013). Differentiation from human pluripotent stem cells of cortical neurons of the superficial layers amenable to psychiatric disease modeling and high-throughput drug screening. Translational Psychiatry, 3, e294.

Botros, H.G., Legrand, P., Pagan, C., Bondet, V., Weber, P., Ben-Abdallah, M., … Bourgeron, T. (2013). Crystal structure and functional mapping of human ASMT, the last enzyme of the melatonin synthesis pathway. Journal of Pineal Research, 54, 46-57.

Delorme, R., Ey, E., Toro, R., Leboyer, M., Gillberg, C., & Bourgeron, T. (2013). Progress toward treatments for synaptic defects in autism. Nature Medicine, 19, 685-694.

El-Kordi, A., Winkler, D., Hammerschmidt, K., Kästner, A., Krueger, D., Ronnenberg, A., ... Ehrenreich, H. (2013). Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behavioural Brain Research, 251, 41-49.

Ey, E., Torquet, N., Le Sourd, A.M., Leblond, C.S., Boeckers, T.M., Faure, P., & Bourgeron, T. (2013). The Autism ProSAP1/Shank2 mouse model displays quantitative and structural abnormalities in ultrasonic vocalisations. Behavioural Brain Research, 256, 677-689.

Huguet, G., Ey, E., & Bourgeron, T. (2013). The genetic landscapes of autism spectrum disorders. Annual Review of Genomics and Human Genetics, 14, 191-213.

Mercati, O., Danckaert, A., André-Leroux, G., Bellinzoni, M., Gouder, L., Watanabe, K., ... Cloëz-Tayarani, I. (2013). Contactin 4, -5 and -6 differentially regulate neuritogenesis while they display identical PTPRG binding sites. Biology Open, 2, 324-334.

Pagan, C., Delorme, R., Launay, J.M., & Bourgeron, T. (2013). Alterations of the Serotonin-Melatonin Pathway in Autism Spectrum Disorders: Biological Evidence and Clinical Consequences. In C., Powell & L.M., Monteggia (Eds.), The Autisms: Molecules to Model Systems. New York: Oxford University Press.

Scheid, I., Maruani, A., Huguet, G., Leblond, C.S., Nygren, G., Anckarsäter, H., .., Delorme, R. (2013). Heterozygous FA2H mutations in autism spectrum disorders. BMC Medical Genetics, 14, 124.

Wang, L., Li, J., Ruan, Y., Lu, T., Liu, C., Jia, M., ... Zhang, D. (2013). Sequencing ASMT identifies rare mutations in Chinese Han patients with autism. PLoS One, 8, e53727.

2012

Anney, R., Klei, L., Pinto, D., Almeida, J., Bacchelli, E., Baird, G., … Devlin, B. (2012). Individual common variants exert weak effects on the risk for autism spectrum disorders. Human Molecular Genetics, 21, 4781-4792.

Bourgeron, T. (2012). Genetics and Epigenetics of Autism Spectrum Disorders. In P.S.,Corsi & Y., Christen, (Eds.), Epigenetics, Brain and Behavior. Berlin, Heidelberg : Springer Berlin Heidelberg

Casey, J.P., Magalhaes, T., Conroy, J.M., Regan, R., Shah, N., Anney, R., … Ennis, S. (2012). A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Human Genetics, 131, 565-579.

Chabout, J., Serreau, P., Ey, E., Bellier, L., Aubin, T., Bourgeron, T., & Granon, S. (2012). Adult male mice emit context-specific ultrasonic vocalizations that are modulated by prior isolation or group rearing environment. PLoS One, 7, e29401.

Chaste, P., Betancur, C., Gérard-Blanluet, M., Bargiacchi, A., Kuzbari, S., Drunat, S., … Delorme, R. (2012). High-functioning autism spectrum disorder and fragile X syndrome: report of two affected sisters. Molecular Autism, 3, 5.

Durand, C.M., Perroy, J., Loll, F., Perrais, D., Fagni, L., Bourgeron, T., … Sans, N. (2012). SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Molecular Psychiatry, 17, 71-84.

Etain, B., Dumaine, A., Bellivier, F., Pagan, C., Francelle, L., Goubran-Botros, H., … Jamain, S. (2012). Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder. Human Molecular Genetics, 21, 4030-4037.

Ey, E., Yang, M., Katz, A.M., Woldeyohannes, L., Silverman, J.L., Leblond, C. S., … Crawley, J.N. (2012). Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4. Genes, Brain & Behavior, (Epub ahead of print).

Le Floch, E., Guillemot, V., Frouin, V., Pinel, P., Lalanne, C., Trinchera, L., … Duchesnay, E. (2012). Significant correlation between a set of genetic polymorphisms and a functional brain network revealed by feature selection and sparse Partial Least Squares. NeuroImage, 63,11-24.

Leblond, C.S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., … Bourgeron, T. (2012). Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genetics, 8, e1002521.

Nava, C., Lamari, F., Héron, D., Mignot, C., Rastetter, A., Keren, B., … Depienne, C. (2012). Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Translational Psychiatry, 2, e179.

Pinel, P., Fauchereau, F., Moreno, A., Barbot, A., Lathrop, M., Zelenika, D., … Dehaene, S. (2012). Genetic variants of FOXP2 and KIAA0319/TTRAP/THEM2 locus are associated with altered brain activation in distinct language-related regions. Journal of Neuroscience, 32, 817-825.

Sato, D., Lionel, A.C., Leblond, C.S., Prasad, A., Pinto, D., Walker, S., … Scherer, S.W. (2012). SHANK1 Deletions in Males with Autism Spectrum Disorder. American Journal of Human Genetics, 90, 879-887.

Schmeisser, M.J., Ey, E., Wegener, S., Bockmann, J., Stempel, A.V., Kuebler, A., … Boeckers, T.M. (2012). Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature, 486, 256-260.

2011

Amaral, D., Rogers, S.J., Baron-Cohen, S., Bourgeron, T., Caffo, E., Fombonne, E., … van der Gaag, R.J. (2011). Against le packing: a consensus statement. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 191-192.

Anney, R.J., Kenny, E.M., O'Dushlaine, C., Yaspan, B.L., Parkhomenka, E., Buxbaum, J.D., ... Autism Genome Project. (2011). Gene-ontology enrichment analysis in two independent family-based samples highlights biologically plausible processes for autism spectrum disorders. European Journal of Human Genetics, 19, 1082-1089.

Ben-Abdallah, M., Bondet, V., Fauchereau, F., Béguin, P., Goubran-Botros, H., Pagan, C., … Bellalou, J. (2011). Production of soluble, active acetyl serotonin methyl transferase in Leishmania tarentolae. Protein Expression and Purification, 75,114-118.

Chaste, P., Clement, N., Botros, H.G., Guillaume, J.L., Konyukh, M., Pagan, C., … Bourgeron, T. (2011). Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders. Journal of Pineal Research, 51, 394-399.

Ey, E., Leblond, C.S., & Bourgeron, T. (2011). Behavioral profiles of mouse models for autism spectrum disorders. Autism Research, 4, 5-16.

Konyukh, M., Delorme, R., Chaste, P., Leblond, C., Lèmiere, N., Nygren, G., … Bourgeron, T. (2011). Variations of the candidate SEZ6L2 gene on Chromosome 16p11.2 in patients with autism spectrum disorders and in human populations. PLoS One, 6, e17289.

Maronde, E., Saade, A., Ackermann, K., Goubran-Botros, H., Pagan, C., Bux, R., … Stehle, J.H. (2011). Dynamics in enzymatic protein complexes offer a novel principle for the regulation of melatonin synthesis in the human pineal gland. Journal of Pineal Research, 51, 145-155.

Pagan, C., Botros, H.G., Poirier, K., Dumaine, A., Jamain, S., Moreno, S., … Bourgeron, T. (2011). Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disability. BMC Medical Genetics, 12, 17.

Poot, M., van der Smagt, J.J., Brilstra, E.H., & Bourgeron, T. (2011). Disentangling the myriad genomics of complex disorders, specifically focusing on autism, epilepsy, and schizophrenia. Cytogenetic Genome Research, 135, 228-240.

2010

Anney, R., Klei, L., Pinto, D., Regan, R., Conroy, J., Magalhaes, T.R., … Hallmayer, J. (2010). A genome-wide scan for common alleles affecting risk for autism. Human Molecular Genetics, 19, 4072-4082.

Chaste, P., Clement, N., Mercati, O., Guillaume, J.L., Delorme, R., Botros, H. G., … Bourgeron, T. (2010). Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population. PLoS One, 5, e11495.

Delorme, R., Betancur, C., Chaste, P., Kernéis, S., Stopin, A., Mouren, M.C., … Launay, J.M. (2010). Reduced 3-O-methyl-dopa levels in OCD patients and their unaffected parents is associated with the low activity M158 COMT allele. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 153B, 542-548.

Delorme, R., Betancur, C., Scheid, I., Anckarsäter, H., Chaste, P., Jamain, S., … Bourgeron, T. (2010). Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls. BMC Medical Genetics, 11,108.

Pinto, D., Pagnamenta, A.T., Klei, L., Anney, R., Merico, D., Regan, R., …. Betancur, C. (2010). Functional impact of global rare copy number variation in autism spectrum disorders. Nature, 466, 368-372.

Toro, R., Konyukh, M., Delorme, R., Leblond, C., Chaste, P., Fauchereau, F., … Bourgeron, T. (2010). Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends in Genetics, 26, 363-372.

2009

Bourgeron, T. (2009). A synaptic trek to autism. Current Opinion in Neurobiology, 19, 231-234.

Bourgeron, T. (2009). Genetics of Autism Spectrum Disorders. In F., Lang (Ed.), Encyclopedia of Molecular Mechanisms of Disease. Berlin, Heidelberg: Springer Berlin Heiderlberg.

Bourgeron T. (2009). Cell Adhesion Molecules in Synaptopathies. In M., Hortsch & H., Umemori (Eds.), The Sticky Synapse. Cell Adhesion Molecules and Their Role in Synapse Formation and Maintenance. New York, NY: Springer.

Gong, X., Delorme, R., Fauchereau, F., Durand, C.M., Chaste, P., Betancur, C., … Bourgeron, T. (2009). An investigation of ribosomal protein L10 gene in autism spectrum disorders. BMC Medical Genetics, 10, 7.

2008

Bourgeron, T. (2008). Genes, Synapses and Autism Spectrum Disorders. In D.J., Selkoe., A., Triller & Y., Christen (Eds.), Synaptic Plasticity and the Mechanism of Alzheimer’s disease. Berlin, Heidelberg: Springer-Verlag.

Durand, C.M., & Bourgeron, T. (2008). Genetic, Neurobiological and Clinical Findings Related to SHANK3 Mutations and 22q13 Chromosomal Rearrangements in Autism Spectrum Disorders. European Psychiatric Review, 1, 58-61.

Gong, X., Bacchelli, E., Blasi, F., Toma, C., Betancur, C., Chaste, P., … Bourgeron, T. (2008). Analysis of X chromosome inactivation in autism spectrum disorders. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 147B, 830-835.

Jamain, S., Radyushkin, K., Hammerschmidt, K., Granon, S., Boretius, S., Varoqueaux, F., … Brose, N. (2008). Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proceedings of the National Academy of Sciences of the United States of American, 105, 1710-1715.

Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G., Anckarsäter, H., … Bourgeron, T. (2008). Abnormal melatonin synthesis in autism spectrum disorders. Molecular Psychiatry, 13, 90-98.

2007

Autism Genome Project Consortium, Szatmari, P., Paterson, A.D., Zwaigenbaum, L., Roberts, W., Brian, J., … Meyer, K.J. (2007). Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics, 39, 319-328.

Bourgeron, T. (2007). The possible interplay of synaptic and clock genes in autism spectrum disorders. Cold Spring Harbor Symposia on Quantitative Biology, 72, 645-654.

Durand, C.M., Betancur, C., Boeckers, T.M., Bockmann, J., Chaste, P., Fauchereau, F., … Bourgeron, T. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics, 39, 25-27.

2006

Belmonte, M.K., & Bourgeron, T. (2006). Fragile X syndrome and autism at the intersection of genetic and neural networks. Nature Neuroscience, 9,1221-1225.

Bourgeron, T., Jamain, S., Granon, S., (2006). Animal Models of Autism: Proposed Behavioral Paradigms and Biological Studies. In G.S., Fisch & J., Flint. Transgenic and Knockout Models of Neuropsychiatric Disorders. Totowa, New Jersey: Humana Press Inc.

Delorme, R., Durand, C.M., Betancur, C., Wagner, M., Ruhrmann, S., Grabe, H.J., … Malafosse, A. (2006). No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects. Biological Psychiatry, 60, 202-203.

Durand, C.M., Kappeler, C., Betancur, C., Delorme, R., Quach, H., Goubran-Botros, H., … Bourgeron, T. (2006). Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 141B, 67-70.

Etain, B., Mathieu, F., Rietschel, M., Maier, W., Albus, M., McKeon, P., ... Leboyer, M. (2006). Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14. Molecular Psychiatry, 11, 685-694.

Persico, A.M., & Bourgeron, T. (2006). Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends in Neurosciences, 29, 349-358.

2005

Delorme, R., Betancur, C., Wagner, M., Krebs, M.O., Gorwood, P., Pearl, P., . . . Bourgeron, T. (2005). Support for the association between the rare functional variant I425V of the serotonin transporter gene and susceptibility to obsessive compulsive disorder. Molecular Psychiatry, 10, 1059-1061.

2004

Bah, J., Quach, H., Ebstein, R. P., Segman, R. H., Melke, J., Jamain, S., … Bourgeron, T. (2004). Maternal transmission disequilibrium of the glutamate receptor GRIK2 in schizophrenia. Neuroreport, 15,1987-1991.

Delorme, R., Krebs, M.O., Chabane, N., Roy, I., Millet, B., Mouren-Simeoni, M.C., … Leboyer, M. (2004). Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport, 15, 699-702.

2003

Bourgeron, T., & Giros, B. (2003). Genetic Markers in Psychiatry. In M., Leboyer & F., Bellivier (Eds.), Psychiatry Genetics Methods and Protocols. Totowa, NJ: Humana Press Inc.

Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I.C., … Bourgeron, T. (2003). Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genetics, 34, 27-29.

2002

Jamain, S., Quach, H., Quintana-Murci, L., Betancur, C., Philippe, A., Gillberg, C., … Bourgeron, T. (2002). Y chromosome haplogroups in autistic subjects. Molecular Psychiatry, 7, 217-219.

Jamain, S., Betancur, C., Quach, H., Philippe, A., Fellous, M., Giros, B., … Bourgeron, T. (2002). Linkage and association of the glutamate receptor 6 gene with autism. Molecular Psychiatry, 7, 302-310.

2001

Jamain, S., Girondot, M., Leroy, P., Clergue, M., Quach, H., Fellous, M., & Bourgeron, T. (2001). Transduction of the human gene FAM8A1 by endogenous retrovirus during primate evolution. Genomics, 78, 38-4.

Jamain, S., Quach, H., Fellous, M., & Bourgeron, T. (2001). Identification of the human KIF13A gene homologous to Drosophila kinesin-73 and candidate for schizophrenia. Genomics, 74, 36-44.

 

 

Contact Information

Thomas Bourgeron

Page Manager: Anna Spyrou|Last update: 10/25/2016
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?